跳至主要内容
临床试验/NL-OMON23562
NL-OMON23562尚未招募不适用

A Prospective, Open-label, Two Arm Parallel Study in Men with Prostate Cancer to Investigate the Effect of Enzalutamide on the Pharmacokinetics (PK) of Oxycodone Following a Single 15 mg Oral Dose of Oxycodone Normal-Release

Deventer Hospital0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ? Males aged = 18 years;
  • ? Diagnosed prostate cancer;
  • ? Treated with enzalutamide 160 mg once daily for 40 days (arm 1)

排除标准

  • ? known metastases in the liver that would affect drug metabolism;
  • ? Child-Pugh classification B or C that would affect drug metabolism;
  • ? known moderate-severe renal dysfunction (GFR <60 ml/min/1.73m2) that would affect drug metabolism;
  • ? gastrointestinal disorders that would potentially alter absorption;
  • ? previous gastric bypass or gastric band surgery;
  • ? known allergy, hypersensitivity or intolerance to normal-release oxycodone;
  • ? a history of drug abuse or treatment for abuse;
  • ? dose-reduction or =5 successive days of treatment interruption of enzalutamide within 40 days prior to the study day (arm 1);
  • ? treatment with enzalutamide within 40 days prior to the study day (arm 2);
  • ? use of oxycodone normal-release within 24 hour prior to oxycodone intake or use of oxycodone extended-release within 2 days prior to oxycodone intake;
  • ? use of other medication that would affect oxycodone metabolism, see section 5.2 and appendix B;
  • ? use of other medication that would affect enzalutamide metabolism, see section 5.2 and appendix B (arm 1).

研究者

相似试验

The Effect Of Enzalutamide on Oxycodone Metabolism... | 临床试验